Michel Moise Habib

Angioslide Ltd. operates as a privately-held medical device company. It offers PROTEUS, an angioplasty device that combines the dual functionality of balloon angioplasty and embolic capture and removal features. The company was founded by Eran Hirszowicz, Amos Nahir and Yoav Turgeman in 2005 and is headquartered in Natanya, Israel.

Enlivex Therapeutics Ltd. develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions. It produces treatment devices for CAR-T cancer treatment procedures, Graft-versus-Host disease resulting from bone-marrow transplantations, solid organ transplantations and an assembly of autoimmune and inflammatory conditions, such as Crohn’s disease, rheumatoid arthritis, gout, multiple sclerosis and other disorders. The company was founded by Dror Mevorach in 2005 and is headquartered in Jerusalem, Israel.

KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel.

BioProtect Ltd. designs, develops and commercializes balloon systems. Its patented technology allows for the design and manufacture of implantable biodegradable balloon products that support a wide range of clinical applications in oncology and surgery. The company’s balloon implant, indicated for prostate cancer patients. BioProtect was founded by Shaul Shohat, Adrian Paz and Abraham Domb in 2004 and is headquartered in Kfar Saba, Israel.

Medi-Tate Ltd. operates as a medical device company. It develops implantable medical devices for the treatment of benign prostate hyperplasia. The firm's product TIND, which designs to alleviate benign prostatic hyperplasia (BPH) symptoms. The company was founded by Ido Kilemnik in 2007 and is headquartered in Or Akiva, Israel.

Agate RM Investments & Medical Technologies Ltd. (Agate) is a venture capital firm founded in 2007 by Dani Naveh. The firm is headquartered in Tel Aviv, Israel.

Ornim Medical Ltd. provides medical devices and monitering tools. The company is headquartered in Kfar Saba, Israel.

Eximore Ltd. develops an ophthalmic medical device. The company was founded by Ishay Attar and Izhar Halahmi in 2014 and is headquartered in Jerusalem, Israel.

Omnix Medical Ltd. develops novel antibiotic agents against resistant pathogenic bacterial strains. The company was founded by Moshik Cohen-Kutner, Rekad Kheredin, Niv Bachnoff, and Rom Lakritz in 2015 and is headquartered in Jerusalem, Israel.

Pi Therapeutics Ltd. develops a proprietary cancer drug. The company was founded by Ori Kalid in March 2015 and is headquartered in Ness Ziona, Israel.

Matar Capital Advisors Ltd. provides financial and strategic advisory services. The private company is based in Tel Aviv, Israel. The Israeli company was founded by Michel Moise Habib. Michel Moise Habib has been the CEO since incorporation.

Minovia Therapeutics Ltd. is a clinical stage company based in Tirat Carmel, Israel. Minovia Therapeutics is developing a therapeutic platform called mitochondrial augmentation technology (mat) that targets the root cause of diseases generated by mitochondrial dysfunction. The platform enriches patients' hematopoietic stem and progenitor cells with healthy mitochondria isolated from an allogeneic or syngeneic source. The Israeli company's initial clinical focus is on rare mitochondrial diseases for which there are no approved treatments, and the lead product, mnv-201, is composed of autologous hematopoietic stem cells enriched with healthy allogeneic mitochondria. Minovia Therapeutics completed an ind enabled phase i/ii clinical trial in Pearson syndrome, a fatal pediatric disease, and is planning to accelerate the clinical development for Pearson syndrome and expand the pipeline to other hematological/mitochondrial-related diseases. The company was founded in 2012 by Natalie Yivgi-Ohana, Uriel Halavee, Ephraim Aharonson, and Natalie Yivgi-Ohana has been the CEO since 2012.

Alive israel Healthtech Fund (Alive) is a venture capital firm founded in 2020 by Rafael Beyar, Michel Habib, Ari Shamiss and Dudi Klein. The firm is headquartered in Tel Aviv, Israel.